Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nutrition Considerations in Duchenne Muscular Dystrophy.

Literature DB >> 25977513

Nutrition Considerations in Duchenne Muscular Dystrophy.

Jillian Davis¹, Emily Samuels¹, Lucille Mullins².

Abstract

Duchenne muscular dystrophy (DMD) is a serious degenerative muscular disease affecting males. Diagnosis usually occurs in childhood and is confirmed through genetic testing and/or muscle biopsy. Accompanying the disease are several nutrition-related concerns: growth, body composition, energy and protein requirements, constipation, swallowing difficulties, bone health, and complementary medicine. This review article addresses the nutrition aspects of DMD.

Entities: Disease

Keywords: Duchenne muscular dystrophy; muscular dystrophies; nutrition assessment; nutrition therapy; nutritional support

Mesh：

Substances：

Year: 2015 PMID： 25977513 DOI： 10.1177/0884533615586202

Source DB: PubMed Journal: Nutr Clin Pract ISSN： 0884-5336 Impact factor: 3.080

Keyword Cloud
Cited

19 in total

1. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors: Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal: J Clin Lipidol Date: 2020-05-29 Impact factor: 4.766

Review 2. Clinical management of Duchenne muscular dystrophy: the state of the art.

Authors: Sonia Messina; Gian Luca Vita
Journal: Neurol Sci Date: 2018-09-14 Impact factor: 3.307

Review 3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors: David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal: Lancet Neurol Date: 2018-02-03 Impact factor: 44.182

4. Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.

Authors: Rebecca Latimer; Natalie Street; Kristin Caspers Conway; Kathy James; Christopher Cunniff; Joyce Oleszek; Deborah Fox; Emma Ciafaloni; Christina Westfield; Pangaja Paramsothy
Journal: J Child Neurol Date: 2017-04-09 Impact factor: 1.987

5. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy.

Authors: Letizia Brogi; Maria Marchese; Alessandro Cellerino; Rosario Licitra; Valentina Naef; Serena Mero; Carlo Bibbiani; Baldassare Fronte
Journal: Nutrients Date: 2021-05-12 Impact factor: 5.717

Nutrition Considerations in Duchenne Muscular Dystrophy.

1. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Review 2. Clinical management of Duchenne muscular dystrophy: the state of the art.

Review 3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

4. Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.

5. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy.

6. ²³Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy.

Review 7. Nutritional Challenges in Duchenne Muscular Dystrophy.

Review 8. Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies.

9. Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice.

10. Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study.

Nutrition Considerations in Duchenne Muscular Dystrophy.

1. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Review 2. Clinical management of Duchenne muscular dystrophy: the state of the art.

Review 3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

4. Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.

5. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy.

6. 23Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy.

Review 7. Nutritional Challenges in Duchenne Muscular Dystrophy.

Review 8. Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies.

9. Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice.

10. Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study.

6. ²³Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy.